Strykervs.Zimmer Biomet
SYK vs ZBH · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices, from surgery and cardiology to robotics.
Stryker is about 7.0× larger than Zimmer Biomet by market cap; Zimmer Biomet trades at the lower P/E (23.1 vs 35.2); year to date, Zimmer Biomet leads (+12.3% vs −6.7%).
Side by side
| SYK | ZBH | |
|---|---|---|
| Market cap | $131B | $18.6B |
| Price | $330.59 | $100.24 |
| Today | +0.8% | −0.7% |
| Return YTD | −6.7% | +12.3% |
| Return 1Y | −16.8% | −6.2% |
| P/E | 35.2 | 23.1 |
| P/S | 5.1 | 2.2 |
| P/B | 5.5 | 1.5 |
Data as of 2026-08-26 · updates daily after U.S. close
The two companies
StrykerSYK
Orthopaedic implants and surgical equipment, with Mako bringing robot assistance into the operating room.
Full SYK profile →More SYK & ZBH comparisons
Other head-to-heads in the Medtech & devices segment.
See where SYK and ZBH sit in the full Medicine, pharma & life science map: every segment from suppliers to end markets.Open the Life science value chain →